Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1122 | 1068 | 1239 | 1159 | 1444 | 1663 |
Fund Return | 12.24% | 6.82% | 23.9% | 5.04% | 7.63% | 5.22% |
Place in category | 483 | 426 | 414 | 222 | 351 | 247 |
% in Category | 72 | 67 | 62 | 38 | 57 | 64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dreyfus Strategic Value I | 5.17B | 24.69 | 15.84 | 11.94 | ||
Dreyfus Stock Index Fund Initial Cl | 3.48B | 27.74 | 11.14 | 13.05 | ||
Dreyfus International Stock I | 3.32B | 1.89 | -0.38 | 6.58 | ||
Dreyfus Fund Incorporated | 2.53B | 31.51 | 13.63 | 14.17 | ||
Dreyfus S&P 500 Index | 2.53B | 27.48 | 10.88 | 12.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 206B | 7.87 | 2.85 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 75.27B | 7.92 | 2.90 | 4.95 | ||
Fidelity International Index Inst | 52.81B | 6.73 | 4.26 | 5.28 | ||
Fidelity Series Global ex US Index | 49.29B | 8.01 | 2.94 | 4.71 | ||
Strategic Advisers International I | 44.53B | 8.62 | 3.15 | 6.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.53 | 754.0 | -3.89% | |
Msci Eafe Sep24 | - | 2.11 | - | - | |
ASML Holding | NL0010273215 | 2.01 | 687.70 | +0.64% | |
Nestle | CH0038863350 | 1.59 | 75.18 | +0.37% | |
AstraZeneca | GB0009895292 | 1.51 | 10,468.0 | -0.95% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Buy | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review